Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
Emma M. Kileel(Boston University), Steven Grinspoon(Massachusetts General Hospital), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Edgar T. Overton(University of Alabama at Birmingham), Nwora Lance Okeke(Duke University), Janet Lo(Harvard University), Pamela S. Douglas(Duke University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Estebán Martínez(Instituto de Salud Carlos III), Princy Kumar(Georgetown University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Esaú João(Hospital Federal dos Servidores do Estado), Markella V. Zanni(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 38
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
|New England Journal of Medicine|2015|1.5k